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Mitochondrial phosphoproteomefeatures of complex I of mammalian and human mitochondria are reviewed. In a
variety of mitotic cell-line cultures, activation in vivo of the cAMP cascade, or direct addition of cAMP,
promotes the NADH–ubiquinone oxidoreductase activity of complex I and lower the cellular level of ROS.
These effects of cAMP are found to be associated with PKA-mediated serine phosphorylation in the conserved
C-terminus of the subunit of complex I encoded by the nuclear gene NDUFS4. PKA mediated phosphorylation
of this Ser in the C-terminus of the protein promotes its mitochondrial import and maturation. Mass-
spectrometry analysis of the phosphorylation pattern of complex I subunits is also reviewed.
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Complex I of the respiratory chain catalyzes the oxidation of NADH
by ubiquinone and conserves the free energy thus made available as a
transmembrane proton gradient [1–4]. In mammalian mitochondria,
complex I is made up of 45 subunits [5], of which seven are encoded
by the mitochondrial genome, the others by nuclear genes [1–4].
Fourteen subunits of the mammalian enzyme, conserved from
prokaryotes to humans, are likely to contribute the essential elements
of the redox and proton translocating activity [1–4]. Some of the
supernumerary subunits appear to be essential for the assembly of the
complex [6–8], for others regulatory function and analogy with
known proteins of other systems are under investigation [4,9,10].
A series of Fe–S redox centers bound to different subunits, in the
hydrophylic moiety of the complex, mediate electron transferhemistry, Biology and Physics,
i, Italy. Tel.: +39 080 5448540;
a).
l rights reserved.from FMN, the ﬁrst redox acceptor from NADH, to protein stabilized
semiquinones in the membrane hydrophobic moiety, from which
electrons are ﬁnally delivered to the ubiquinone of the membrane
pool [1–4,11,12]. The NADH–ubiquinone oxidoreductase activity of the
membrane associated complex I of mammals and certain prokaryotes
is coupled with proton pumping from the inner (N) side to the outer
(P) side of the membrane, with a mechanistic upper limit H+/e−
stoicheiometry of 2, as compared to 2 and 1 in complex III and IV of the
respiratory chain respectively [4,13–15]. It has, however, been
observed that, when in isolated mitochondria electron transfer in
the respiratory chain is activated by the addition of a substrate of NAD-
linked dehydrogenase, the H+/e− stoicheiometry for proton pumping
at the ﬁrst coupling site of the chain apparently decreases well below
2 as the rate of electron ﬂow is raised [16].
In mitochondria isolated from different rat-tissues a decrease of
the P/O ratio for oxidative phosphorylation at the ﬁrst coupling site
has also been observed at high rates of electron ﬂow [17]. Occurrence
of slip in the proton pump of both complex III and complex IV has been
previously observed [15,18]. A possible decline of the H+/e− stoicheio-
metry at the ﬁrst coupling site of oxidative phosphorylation is an
intriguing aspect that should be revisited in whole mitochondria and
in the isolated complex I.
720 S. Papa et al. / Biochimica et Biophysica Acta 1777 (2008) 719–728There are observations pointing to a role in proton pumping of
protein bound ubisemiquinone species [12,19,20] and redox-linked
protolytic conformational changes of subunits, like the PSST subunit
in the bovine enzyme (NDUFS7 gene, NuoB of the E. coli enzyme)
[21]. The N2 iron–sulfur center bound to this subunit, serving as the
ﬁnal electron transfer center in the sequence of redox carriers from
FMN to protein-stabilized ubisemiquinone, exhibits a pH dependent
redox potential, due to pK changes of nearby amino acid residues
[22,23].
In 1994Papa et al. [24] proposed that a protein stabilizedUQU−/UQH2
couple, transferring 2H+ per e−, could represent the critical element of
the pump in complex I, in combinationwith cooperative H+/e− coupling
in redox proteins. On this basis Papa et al. [15] developed a Q-gated
proton pump model (Fig. 1), in which cooperative redox linked H+
transfer by the N2-PSST subunit mediated proton consumption from
the N space in the reduction of a protein stabilized UQU− to UQH2.
Protons were then released towards the P space, upon electron transfer
from this UQH2, directly to the ubiquinone of the pool (versionA) or to a
protein-stabilized UQ/UQU− couple and from this to the ubiquinone of
the pool (version B). The work of Ohnishi and Salerno [19,20], showing
the existence in complex I of two protein-bound ubisemiquinone
anions, one of which (UQU−Nf) accumulates in the presence of
transmembrane ΔμH+ and is directly spin coupled with the N2 centerFig. 1. Q-gated proton pump model in Complex I. A protein stabilized UQ
U− takes up 2H+
from the N space upon its reduction to UQH2 by the N2 center. Upon oxidation of UQH2
to UQ
U−, directly by UQ of the pool (Version A) or via a protein stabilized UQ/UQ
U− couple
(acting as an electron transfer center), 2H+ are released in the P space. Reproduced with
permission from Papa et al. [15].at the inner membrane surface, seems to provide direct support for
version (B) of theQ-gatedprotonpumpmechanism shown in Fig.1 [15].
The observed rate-dependent decline in the H+/e− stoicheiometry for
proton pumping at the ﬁrst coupling site could be associated with
modulation of the protonmotive electron transfer sequence in the
model shown in Fig. 1.
The present paper reviews features of the regulation by cAMP of
complex I and production of oxygen free radicals in mammalian and
human cell cultures, the role of the NDUFS4 subunit and the phos-
phorylation pattern of constituent subunits of the complex.
2. Regulation by the cAMP cascade of complex I and oxygen free
radical balance
In mammalian cells the redox activity of complex I changes
substantially in the various phases of the cell cycle. Arrest of
ﬁbroblast division in the G0 phase, caused by serum deprivation, is
accompanied by decrease in the NADH ubiquinone oxidoreductase
activity of complex I as compared to cells in the exponential growth
phase [25–28]. Fibroblast reintroduction in the replicative cycle by
adding back serum to serum-starved cells results, after 24 h, in
signiﬁcant enhancement of the NADH ubiquinone oxidoreductase
activity and content of complex I (unpublished observation of the
authors). If instead of serum addition, the cAMP cascade is activated
or dibutyryl-cAMP is directly added to serum-starved cells, in 30 min
an interval in which serum has no effect, the NADH–ubiquinone
oxidoreductase activity is activated more than two fold [25–28]. This
activating effect of cAMP, which is abrogated by inhibitors of cAMP-
dependent protein kinase A (PKA) [27], is generally observed in a
variety of mitotic cells (Fig. 2A) [28]. No change in the activity of
complex IV is, on the other hand, caused by cAMP in this time
interval [25–28].
Confocal microscopy analysis has shown that the decline in the
NADH–ubiquinone oxidoreductase activity in serum starved cells is
accompanied by increase in the cellular level of H2O2 and in the
intramitochondrial level of OU−2 (Fig. 2B) [28]. The addition of
dibutyryl-cAMP results, in the same time interval in which NADH–
ubiquinone oxidoreductase is activated, in disappearance of H2O2
and OU−2 from the cells. This effect of cAMP, which is also abrogated by
inhibitors of PKA, was observed in all the cell lines in which the
NADH–ubiquinone oxidoreductase was activated by the cyclic
nucleotide (Fig. 2-B) [28]. Under these conditions cAMP did not
exert any effect on components of ROS scavenger systems, like
glucose-6-phosphate, glucose-6-phosphate dehydrogenase, total
glutathione, reduced glutathione, glutathione reductase, Cu/ZnSOD,
MnSOD, glutathione peroxidase, glutaredoxin, catalase, (Fig. 3) [28].
If one takes into account that complex I is the major site of OU−2
production in the respiratory chain [4,29,30] it can be argued, from
the above, that the decrease in the ROS level effected by cAMP is
associated with the activation of the forward NADH–ubiquinone
oxidoreductase activity.
In murine and human cell cultures, activation of the cAMP cascade
or direct addition of cAMP has been found to promote, under con-
ditions in which they result in activation of complex I and counteract
ROS accumulation [28], serine phosphorylation in the subunit of the
complex encoded by the nuclear NDUFS4 gene [25–27].
The human NDUFS4 gene, and the corresponding genes in
mammals and birds encode for highly homologous proteins (Fig. 4).
These proteins, but also those of Drosophila and Anopheles, which
present a low overall homologywith the human species, have a highly
conserved C-terminus in which a canonical RVSTK phosphorylation
site in the last residues, with the highest phosphorylation score for
phosphorylation by PKA, is present. The human NDUFS4 gene has,
also, been found to be a hotspot for mutations. So far, 5 different
pathological homozygous mutations have, in fact, been reported for
this gene [4,26,31–33] (Fig. 5).
Fig. 2. Effect of cAMP on the activities of NADH-UQ oxidoreductase of complex I, cytochrome c oxidase of complex IV and ROS levels in different human andmurine cell cultures. Cells
grown in the exponential phase in the presence of 10% fetal bovine serum (FBS) in DMEM (a) were brought into G0 phase by 48 h serum deprivation (0.5% FBS) (b). Serum starved cells
were then treated for 60 min with 100 µM dibutyryl-cAMP+ 100 µM IBMX (c). Panel A, complex I and complex IV activities represent the means±S.E.M. of three or more
determinations in mitoplasts isolated from the cells. Panel B, confocal microscopy quantitative analysis was used to determine the cellular content of H2O2 by the green ﬂuorescence
of 2′-7′-dichloroﬂuorescin-diacetate (DCF-DA) and mitochondrial O2
U− by the red ﬂuorescence of the MitoSox dye. Reproduced with permission from [28].
Fig. 3. Effect of serum starvation and cAMP on ROS scavenger systems in different human
andmurine cell cultures. Changes in the pattern of components of ROS scavenger systems in
cell cultures. 1, changes induced in cell cultures by serum starvation for 48 h vs cells in the
exponential growthphase;2, changes after60min. treatmentwith100µMdibutyryl-cAMP+
100 µM IBMX of serum starved cells, vs starved cells. Table compiled from data in [28].
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ubiquinone oxidoreductase activity of complex I, produced in mouse
myoblast cultures by enhancement of intracellular cAMP with
cholera toxin, is accompanied by serine phosphorylation in the
18 kDa protein band of the complex (Panel A). Direct treatment of the
mitoplasts isolated from myoblasts with dibutyryl-cAMP promoted,
in fact, serine phosphorylation in the RVSTK C-terminus site of the
NDUFS4 protein (Panel B), recognized by a speciﬁc antibody raised
against a synthetic peptide of the phosphorylated C-terminus of the
protein [27]. This phosphorylation and the accompanying stimula-
tion of NADH–ubiquinone oxido-reductase activity, produced by
dibutyryl-cAMP, were both abolished by the PKA inhibitor, H89
(Panel B).
Involvement of phosphorylation of the NDUFS4 subunit, in the
modulation of the redox activity of complex I, is supported by the
ﬁnding that in a neurological patient a pathological 466–470
AAGTC base duplication in the NDUFS4 gene, which results in a
frame shift with 14 amino acids elongation of the protein and
abrogation of the serine phosphorylation site, caused disappear-
ance of the subunit encoded by the gene and abolishment of the
cAMP-dependent serine phosphorylation of complex I in the
patient's ﬁbroblasts [26]. This and other pathological NDUFS4
mutations, found in different neurological patients [4,31] resulted
in disappearance of the protein encoded by the gene, almost
complete inhibition of NADH–ubiquinone oxidoreductase, sup-
pression of a last step in the assembly of complex I [6,31]. These
Fig. 4. Sequence alignment of the 18 kDa (NDUFS4) subunit of mitochondrial complex I in higher eukaryotes (Human gi: 3287881, Bovine gi: 400578, Mouse gi: 6754814, Gallus
gi: 19110803, Anophele gi: 31199457, Drosophila gi: 17944526). Sequences were obtained from Swiss-Prot Database and aligned with EMBL engine. Synthetic peptides used to
produce antibodies against the amino- and carboxy-terminal regions of the protein are shaded in gray. The highly conserved C-terminal segment with the putative canonical
phosphorylation consensus sites (RVS) for PKA is boxed. Known mitochondrial import sequences are underlined. Alternative cleavage sites of presequences are indicated by
arrows.
Fig. 5. Schematic representation of 5 different NDUFS4 gene mutations found in
neurological patients with Complex I deﬁciency. The IVS1nt-1,G→ A splice acceptor site
mutation in intron 1 produced a transcript skipping exon 2; the AAGTC 466–470 Dupl
caused a frame shift with 14 amino acids elongation of the protein and abrogated the
phosphorylation site in the C-terminus. The other mutations introduced premature
termination codons. From refs. [4,31,32].
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phosphorylation of the NDUFS4 subunit could modulate, at least in
cell cultures in vivo, the redox activity of complex I. It has to be
stressed that cAMP fails to activate complex I in isolated mam-
malian mitochondria or in the puriﬁed bovine complex (supple-
mented with PKA) [34]. Could phosphorylation of the NDUFS4
subunit modulate the activity of complex I by promoting import/
assembly of complex I? Whilst we carried out experiments on the
mitochondrial import of the NDUFS4 protein a paper of Lazarou
et al. [33] was published showing that in vitro synthesized NDUFS4
protein is, in less than 60 min, incorporated in mature complex I
in isolated human ﬁbroblast mitochondria, apparently in exchange
with preexisting, possibly damaged, subunit in the complex.
These authors also showed that in vitro synthesized NDUFS4 sub-
unit restored a last step in complex I assembly, impaired in
ﬁbroblasts from a patient with NDUFS4 mutation [33].
In Fig. 7 experimental observations on the import into isolated
mitochondria of [35S]Met-labelled NDUFS4 and ESSS human sub-
units of complex I, synthesized in vitro in the reticulocyte system, are
presented. The human NDUFS4 has two conserved serine phosphor-
ylation consensus sites one in the NH2-terminal leader sequence, the
other in the carboxy-terminal tail (Fig. 4). The human ESSS subunit,
encoded by the nuclear gene NDUFB11, has only one serine
phosphorylation consensus site, at the junction between the leader
and the mature sequence. The bovine ESSS has also a consensus
serine phosphorylation site in the mature sequence [35], which is,
however, absent in the human subunit (EMBL Data Bank). The
precursor forms of the [35S]Met labelled NDUFS4 and ESSS proteins
did bind to the mitochondrial surface, where both were digested byadded trypsin. The ESSS protein was almost completely imported
into mitochondria and converted to the mature, trypsin resistant,
form by the canonical Δψ and ATP dependent translocation process
[36]. Under the same conditions the import into mitochondria and
maturation of the NDUFS4 proteinwas poor (compare panels A and B
of Fig. 7). Addition to the import system of PKA and ATP, which had
no effect on the binding of [35S]Met-labelled NUDFS4 and ESSS
precursor proteins to the surface of mitochondria, promoted Δψ
dependent accumulation into mitochondria of the mature form of
the NDUFS4 protein. The addition of AP suppressed, on the contrary,
the appearance in mitochondria of the mature NDUFS4 protein
(panel C, Fig. 7). At difference with these effects on the NDUFS4
protein, PKA and AP had no inﬂuence on the accumulation in
mitochondria of themature form of the ESSS protein (panel D, Fig. 7).
Fig. 6. cAMP dependent activation of the NADH ubiquinone oxidoreductase activity
and phosphorylation of serine in the NDUFS4 subunit of complex I in murine C2C12
myoblasts. Panel A, mitoplasts separated from control myoblasts (a) and from
myoblasts treated 3 h with cholera toxin+ IBMX (b) were subjected to blue native
electrophoresis which resulted in separation of complexes I, III, IV and V. After blue
native electrophoresis, the protein band corresponding to complex I, from control
(a) and cholera toxin treated myoblasts (b), was cut and subjected to SDS-PAGE.
Proteins were electrotransferred to nitrocellulose sheets and immunoblotted with
an anti-phosphoserine antibody. The histograms on the right represent Vmax of
rotenone-sensitive NADH ubiquinone oxidoreductase measured in sonicated myo-
blasts. Panel B, mitoplasts isolated from control myoblasts were incubated in the
absence or in the presence of dibutyryl-cAMP or in the presence of H89. Complex I,
separated by blue native PAGE, was resolved into its constituent subunits by SDS-PAGE.
Proteins, electrotransferred to nitrocellulose sheet, were immunoblotted with anti-
bodies against synthetic peptides of the phosphorylated C-terminus or N-terminus
respectively. Histograms on the right show the Vmax of rotenone-sensitive NADH
ubiquinone oxidoreductase activity of mitoplasts. Data reproduced with permission
from [27].
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synthesis of the NDUFS4 proteinwas without effect on the binding of
the [35S]Met labelled NDUFS4 precursor protein at the mitochondrial
outer surface, but abolished completely the appearance of the
mature NDUFS4 protein in the inner mitochondrial compartment
(panel E, Fig. 7).
In HeLa cells transfected with a construct of wild NDUFS4 cDNA,
the precursor form of the overexpressed protein was detectable in
the cytosolic fraction, whilst in the mitochondrial fraction only the
mature NDUFS4 protein was present (Fig. 8). Treatment of trans-
fected HeLa cells with H89, prevented the accumulation in
mitochondria of the mature NDUFS4 protein. When HeLa cells
were transfected with a construct of the NDUFS4 cDNA with S173A
substitution, the precursor form of the NDUFS4 protein accumulated
in the cytosol, but no mature NDUFS4 protein, in addition to the
endogenous content, appeared in mitochondria (Fig. 8).Semiquantitative analysis of the precursor and mature [35S]
Met-labelled NDUFS4 protein in the cytosolic and mitochondrial
fractions in the course of the import of the protein showed that, in
the presence of PKA, no trace of the mature NDUFS4 was detectable
in the supernatant during its progressive accumulation in mito-
chondria (Fig. 9-A). Parallel experiments revealed that, in the
presence of AP, which depressed accumulation of [35S]Met-labelled
mature NDUFS4 protein in mitochondria, a signiﬁcant amount of
the mature form rapidly appeared in the supernatant, from where
it then progressively disappeared (Fig. 9-A). Addition of the
cytosolic Hsp70 antibody to the in vitro mitochondrial import
mixture had no effect on the binding of [35S]Met-labelled precursor
of the NDUFS4 protein to the mitochondrial surface but depressed
the PKA dependent accumulation in mitochondria of the ma-
ture form of the protein which now appeared in the supernatant
(Fig. 9-B). Under the same experimental condition a β-actin anti-
body had no effect on the accumulation of the mature NDUFS4
protein in mitochondria, neither it caused its appearance in the
supernatant (Fig. 9-B).
3. Phosphorylation of complex I subunits
Papa et al ﬁrst found that in isolated bovine heart mitochondria
cAMP promotes, among others, phosphorylation of 18 kDa protein
(s) [37], which were shown to be associated with the inner
mitochondrial membrane [38] and the isolated complex I [39].
Edman sequencing of the 18 kDa protein band of the puriﬁed
complex, showed the presence of two subunits of complex I,
namely the GDHG and AQDQ proteins (NDUFS4 gene), the latter of
which corresponded to the band with phosphorylated-serine [39].
Subsequent work of Chen et al. conﬁrmed PKA-dependent
phosphorylation of 18 kDa protein(s) in bovine heart mitochondria
[35]. Extensive analytical work of these authors, using 32P-
radiolabelling, reverse phase HPLC, mass spectrometry and
Edman sequencing showed, in the 18 kDa bands of bovine complex
I PKA-dependent serine phosphorylation of the ESSS subunit, but
did not reveal phosphorylation of the AQDQ. It should be recalled
that the ESSS protein is difﬁcult to be sequenced and was identiﬁed
as a constituent complex I subunit by Carroll et al. [40] after our
work of 1996 [39]. These observations prompted us to revisit the
phosphorylation of 18 kDa protein(s) of puriﬁed bovine heart
complex I by 2D isoelectrofocusing/SDS-PAGE electrophoresis,
radiolabelling, immunoblotting and mass spectrometry. The 2D
electrophoretic separation showed the presence in complex I of a
32P-labelled protein band, recognized by the antibody speciﬁc for
the serine-phosphorylated carboxy-terminus of AQDQ, with an
alkaline isoelectric point and M.W. proper of this subunit
(unpublished observation of the authors). It should be noted that
the ESSS protein which has an acidic isoelectric point, since of its
hydrophobic nature, does not enter the 3–10 pH gradient strip
used for the analysis [40].
Results of systematic mass spectrometry analysis of the
phosphorylation pattern of subunits of complex I isolated from
bovine heart mitochondria are summarized in Table 1 [41].
Phosphopeptide directed MS3 mass spectrometry conﬁrmed the
presence of serine phosphorylated 42 kDa [42], ESSS [35] and
B14.5a [43] subunits. In particular whilst phosphorylated ESSS was
found only in the complex from mitochondria incubated with ATP
and PKA, the phosphorylated forms of 42 kDa and B14.5a were
found in the samples from both control and PKA treated mito-
chondria. The same analytical procedure revealed two new
threonine-phosphorylated subunits of complex I, namely B14.5b
and B16.6. Mass spectrometry detected both the phosphorylated
and non phosphorylated form of these two proteins as well as
of the 42 kDa and B14.5a subunits. Thus these four subunits
undergo a dynamic condition of phosphorylation, as expected for a
Fig. 7.Mitochondrial import of NDUFS4 and ESSS subunits of complex I and effect of PKA and AP on their in vitro mitochondrial import. Full-length human NDUFS4 wild type
(panels A, C and E), mutated Ser173Ala NDUFS4 (panel E) and ESSS (panels B and D) cDNAs were cloned in pCDNA3.1(+) vector containing the T7 promoter and used for
in vitro transcription and translation in Rabbit Reticulocyte Lysate System (RRL), supplemented with [35S]Met. Proteins obtained by the RRL translation system, were added to
the import mixture containing isolated rat liver mitochondria and an ATP energy supplying system. After 60 min. incubation at 30 °C. mitochondria were spun down and
analyzed by autoradiography. Panels A and B, lanes 1, aliquots of the RRL translation mixture were directly analyzed by autoradiography. Lanes 2–6, RRL translation mixture
were added to the import mixture, containing rat liver mitochondria. Mitochondria were spun down from the import mixture before (lanes 2) or after trypsin treatment, in
the absence (lanes 3) or in the presence of Triton X-100 (lanes 4). Lanes 5: valinomycin was added to the import mixture. Lanes 6: the energy supply mixture was omitted.
Aliquots of the samples were subjected to western blotting with antibody against the 39-kDa subunit of complex I. Panel C, lane 1 autoradiogram of the RRL translation
mixture; lane 2, control import mixture; lanes 3 and 7, import mixture supplemented with PKA plus NaF; lane 4, after 60 min of import incubation, in the presence of PKA,
trypsin was added; lane 5, as lane 4 with the addition of Triton X-100 together with trypsin; lane 6, import incubation in the presence of; lane 8, import incubation in the
presence of PKA and valinomycin. Aliquots of the samples were subjected to western blotting with antibody against the 39-kDa subunit of complex I. Panel D, lane 1
autoradiogram of the RRL translation mixture; lane 2, control import mixture; lane 3, import mixture supplemented with PKA; import incubation in the presence of PKA
followed by trypsin treatment; lane 5, import incubation in the presence of PKA followed by trypsin treatment plus Triton X-100; lane 6, import incubation in the presence of
AP. Panel E, the mitochondrial import/maturation of the radiolabelled native and mutated NDUFS4 protein was analyzed as described above. Lanes 1, direct autoradiography
of the RRL translation mixtures; lanes 2 and 3, no addition (autoradiography before, lanes 2, and after trypsin treatment of mitochondria, lanes 3); lanes 4 and 5, import
incubation in the presence of PKA plus NaF (autoradiography before, lanes 4, and after trypsin treatment of mitochondria, lanes 5); lanes 6 and 7, import incubation in the
presence of 10 U AP (autoradiography before, lanes 6, and after trypsin treatment of mitochondria, lanes 7. Reproduced with permission from [36]. Panels A and B from Fig. 3
in [36] and panels C, D and E from Fig. 4 in [36]. See [36] for experimental details.
724 S. Papa et al. / Biochimica et Biophysica Acta 1777 (2008) 719–728physiological regulatory process. Both B14.5a and B14.5b subunits
are N-acetylated [44]. Phosphorylation of these subunits, which
are located at the matrix side and in the membrane arm of the
complex, might have an impact on its conformation and activity.
Subunit B16.6 has been identiﬁed as the product of the GRIM-19
gene [9]. This subunit seems to be essential for the assembly or
stability of complex I and cell death [45]. The ﬁnding that the
deletion of the C-terminus of GRIM19, where the threonine phos-
phorylation site is located, suppresses its death promoting effect
seems to be relevant in this context [45,46].
In agreement with the observations of Chen et al [35], our
attempts to verify by mass spectrometry phosphorylation of the
AQDQ subunit in PKA treated bovine heart complex I have so far
been unsuccessful. The speciﬁc location of the serine phosphoryla-
tion site at the C-terminal end (...RVSTK-COOH) of the AQDQ
protein could make mass detection of the small phosphorylated
peptide resulting from proteolysis difﬁcult. The eventual phos-
phorylated peptide can, furthermore, escape mass spectrometry
detection if present in small percentage with respect to the non-
phosphorylated peptide, also since of its lower tendency to be
ionized, as it was observed by directly comparing the ioniza-tion signal arising from the non-phosphorylated and phosphory-
lated C-terminal synthetic peptides of the protein (unpublished
observations of the authors). An alternative possibility is that the
AQDQ is ﬁnally assembled in the mature complex in the non-
phosphorylated form and in a location where it becomes inacces-
sible to PKA. The question arises here to what extent the
failure to detected by mass spectrometry the phosphorylation of
the C-terminus of the AQDQ protein in the bovine complex I stands
against the evidence of phosphorylationprovidedby the2-dimentional
isoelectrofocusing/SDS electrophoretic pattern, radiolabelling and
immunodetection by speciﬁc antibodies. In any case it seems to us
that the apparently contradictory results obtained on isolated
bovine heart mitochondria and puriﬁed bovine complex I can hardly
be applied to the situation met in native conditions in cells from
other species, in which there is converging evidence, from inde-
pendent biochemical and genetic lines, for a physiological role of
phosphorylation of this subunit. In nature there occur species speciﬁc
(see for example Fig. 4) and, within a species, tissue speciﬁc
protein isoforms and different enzyme afﬁnities for substrates. Further
mass spectrometry analysis in combination with radiolabell-
ing, chemical peptide degradation and immunochemical detection
Fig. 9. Inhibition by anti Hsp70 antibody of the mitochondrial import of the NDUFS4
protein. Panel A, NDUFS4 protein was translated in the RRL systems with 35S labelled
methionine. The import incubation was carried out as described the legend to Fig. 7, in
the presence of AP or PKA for the time speciﬁed in the ﬁgure. After incubation the
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pattern of this and other subunits of complex I [35,41,47,48].
4. Conclusions
The mitochondrial import of the NDUFS4 subunit, which is es-
sential for the last step of the assembly of a functional complex
[6,7,33], is promoted by its PKA-dependent phosphorylation at
serine 173 in the C-terminus [36]. It has been reported that the
mitochondrial import of other proteins like cytochrome P4502B1
[49], CYP2E1 [50] and glutathione S-transferase [51] is also pro-
moted by PKA-mediated phosphorylation. Mitochondrial import of
nuclear encoded subunits of oxidative phosphorylation complexes
is mediated by the concerted action of cytosolic Hsp chaperons, the
TOM/TIM multiprotein complexes, inner-mitochondrial compart-
ment maturase(s) and ATP-dependent mitochondrial chaperons
[52]. The precursor proteins are brought in an extended transloca-
tion-competent conﬁguration and pushed into the TOM/TIM
membrane system by cytosolic Hsp chaperons [53]. Active translo-
cation of the precursors in the TOM/TIM system, driven by the
membrane potential, is further assisted by the ATP-dependent
pulling activity of mitochondrial Hsp proteins [54]. Translocation of
proteins by the TOM-TIM system is a reversible process. Intrami-
tochondrial processed mature proteins can undergo retrograde
diffusion into the cytosol [53,55]. The ﬁndings reviewed in section 2
(Fig. 9) indicate that phosphorylation of the NDUFS4 protein, rather
than stimulating the active penetration of the protein into
mitochondria, where it is proteolytically converted to the mature
form, it inhibits passive retrograde diffusion of the mature NDUFS4
protein into the cytosol where it is proteolytically degraded. Themitochondrial and supernatant proteins were analyzed by SDS-PAGE and autoradio-
graphy. Panel B, lane 1, import incubation in the presence of AP; lane 2, import
incubation in the presence of PKA; lane 3, import incubation in the presence of AP plus
cHsp70 antibody; lane 4, import incubation in the presence of PKA plus cHsp70
antibody; lane 5, import incubation in the presence of AP plus β-actin antibody; lane 6,
import incubation in the presence of PKA plus β-actin antibody. Reproduced with
permission from [36], see this reference for details.
Fig. 8. Effect of H89 and S173A mutation on the cytosolic and mitochondrial level of the
precursor and mature form of the NDUFS4 protein respectively in HeLa cells transfected
with the cDNA construct of the gene. After transfection, cells were harvested and
mitoplasts (panel A) and cytosolic (panel B) fractions isolated. Proteins were resolved by
SDS-PAGE and immunoblotted with the NDUFS4 NH2-terminus antibody. Lanes 1,
control HeLa cells; lanes 2, HeLa cells transfected with the empty vector; lanes 3, cells
transfected with wild NDUFS4 cDNA construct; lanes 4, cells transfected with wild
NDUFS4 cDNA construct and incubated in the presence of H89; lanes 5, cells transfected
with S173A mutant NDUFS4 cDNA construct. Proteins were also immunoblotted with
the antibodies speciﬁed on the panels. Reproduced with permission from [36], see this
reference for details.inhibition by PKA of retrograde release from mitochondria of the
mature NDUFS4 protein appears to be associated with binding of
the C-terminus phosphorylated protein to the cytosolic Hsp70. This
can contribute to hold transiently the C-terminus of the mature
NDUFS4 protein at the outer surface of mitochondria thus
preventing its retrograde diffusion into the cytosol, till it is ﬁnally
assembled in complex I (Fig. 10) [36,55]. Further work is in progress
to verify whether the stimulation by PKA of the mitochondrialTable 1
Pattern of the phosphorylation state of bovine heart complex I subunits revealed by
mass spectrometric analysis
Phosphoproteins Complex I from control bovine
heart mitochondria
Complex I from PKA-treated
bovine heart mitochondria
42 kDa 47LITVDGNICSGKpSK60 47LITVDGNICSGKpSK60
LITVDGNICSGKSK LITVDGNICSGKSK
B16.6 105VGESVFHTpTR114 105VGESVFHTpTR114
105VGESVFHTTR114 105VGESVFHTTR114
B14.5a 93AVpSPAPPIK101 93AVpSPAPPIK101
92KAVSPAPPIKR102 92KAVSPAPPIKR102
B14.5b 9ApTFQFLPDEAR19 9ApTFQFLPDEAR19
9ATFQFLPDEAR19 9ATFQFLPDEAR19
ESSS 47RPpSEPTLR54
The phosphopeptides were detected after their enrichment by TiO2 column
cromatography of the trypsin in-gel digest. Nonphosphorylated peptides were
detected in the trypsin in-gel digest before TiO2 enrichment. Phosphorylation
analysis was performed by MS3 mass spectrometry. Data reproduced with permission
from [41].
726 S. Papa et al. / Biochimica et Biophysica Acta 1777 (2008) 719–728import of the NDUFS4 subunit is directly involved in the promot-
ing effect exerted by cAMP, in cell cultures in vivo, on the activity
of complex I and prevention of cellular accumulation of reactive
oxygen species.
The NADH–ubiquinone oxidoreductase activity is impaired
and oxygen superoxide production enhanced in complex I by
thiol oxidation and mixed disulﬁde glutathionylation of some of its
subunits, like the 75 kDa (NDUFS1 gene), 51 kDa (NDUFV1 gene)
and TYKY (NDUFS8 gene) [56,57]. A pathological homozygous
hereditary Q522 K replacement in the 75 kDa subunit (NDUFS1
gene) has been found to result in decreased content of the
protein, impairement of the NADH ubiquinone oxidoreductase
activity, mitochondrial membrane potential and cellular ROS accu-
mulation [58] (Fig. 11). These last effects were counteracted by
cAMP.
The phosphorylation state of the NDUFS4 subunit, as well as of
other subunits of complex I [41–43,47,48,58–60], by PKA, or
different protein kinases which impinge on mitochondrial func-
tions [61,62], may be interrelated with the redox state of theFig. 10. Scheme describing the impact of serine phosphorylation in the C-terminus on the m
C-terminusmediates binding of the NDUFS4 protein to the cytosolic Hsp70. Binding of the N
in unfolded translocation competent conﬁguration and prevents retrograde release fromm
has been removed.subunits, their susceptibility to oxidative damage and/or proteoly-
tic turnover [63]. Disregulation of these processes appears to be
involved in complex I dysfunction associated with neurological
disorders [62,64].
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